Profound Medical (TSE:PRN) has released an update.
Profound Medical Corp., a developer of incision-free therapies for diseased tissue ablation, is set to present a business update at the 2024 Bloom Burton & Co. Healthcare Investor Conference in Toronto. The event will be broadcast live from the Metro Toronto Convention Centre, highlighting their flagship technologies, TULSA-PRO and Sonalleve, which offer innovative treatments for prostate conditions and uterine fibroids, respectively.
For further insights into TSE:PRN stock, check out TipRanks’ Stock Analysis page.
